Suppr超能文献

结直肠癌诊断、分期及治疗管理的当前选择

Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer.

作者信息

Nakayama Goro, Tanaka Chie, Kodera Yasuhiro

机构信息

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Gastrointest Tumors. 2013 Sep;1(1):25-32. doi: 10.1159/000354995. Epub 2013 Sep 12.

Abstract

BACKGROUND

Colorectal cancer (CRC) is the one of the most common malignancies and is a leading cause of cancer death worldwide. The incidence of mortality from CRC has decreased in Western countries because of earlier diagnosis and improved treatment modalities; however, mortality is still increasing in most other regions of the world.

SUMMARY

Progress in the development of imaging modalities has enabled more accurate staging based on the TNM classification. The therapeutic management of CRC should involve a multi-modal approach, including high-quality surgery and an optimal choice of chemotherapy and radiotherapy regimens according to disease characteristics and patient preferences. Even in the case of metastatic disease, the optimal multi-modal treatments could achieve potential cure or long-term survival benefit in some patients. The aim of this review is to present current options regarding the diagnosis, staging and treatment management for CRC based on published research reports and the current management guidelines.

摘要

背景

结直肠癌(CRC)是最常见的恶性肿瘤之一,也是全球癌症死亡的主要原因。在西方国家,由于早期诊断和治疗方式的改进,CRC的死亡率有所下降;然而,在世界其他大多数地区,死亡率仍在上升。

总结

成像技术的发展进步使得基于TNM分类的分期更加准确。CRC的治疗管理应采用多模式方法,包括高质量的手术以及根据疾病特征和患者偏好优化选择化疗和放疗方案。即使是转移性疾病,最佳的多模式治疗也能使一些患者获得潜在治愈或长期生存益处。本综述的目的是根据已发表的研究报告和当前的管理指南,介绍CRC诊断、分期和治疗管理的当前选择。

相似文献

1
Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer.
Gastrointest Tumors. 2013 Sep;1(1):25-32. doi: 10.1159/000354995. Epub 2013 Sep 12.
4
Review on the immunotherapy strategies against metastatic colorectal carcinoma.
Immunotherapy. 2016 Oct;8(10):1245-61. doi: 10.2217/imt-2016-0045.
5
Colorectal cancer: Recent advances in management and treatment.
World J Clin Oncol. 2024 Sep 24;15(9):1136-1156. doi: 10.5306/wjco.v15.i9.1136.
6
Colon Cancer Screening - Is It Time Yet?
J Coll Physicians Surg Pak. 2017 Jun;27(6):327-328.
7
PET/CT: will it change the way that we use CT in cancer imaging?
Cancer Imaging. 2006 Oct 31;6(Spec No A):S52-62. doi: 10.1102/1470-7330.2006.9012.
9
[Looking back 2018--focused on colorectal cancer].
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):9-16.

引用本文的文献

1
Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm.
Inflammopharmacology. 2025 Sep 15. doi: 10.1007/s10787-025-01925-5.
2
Accuracy of Clinical Staging of Localized Colon Cancer: A National Cancer Database Cohort Analysis.
Ann Surg Oncol. 2024 Oct;31(10):6461-6469. doi: 10.1245/s10434-024-15875-9. Epub 2024 Jul 29.
3
Current trends and future prospects of drug repositioning in gastrointestinal oncology.
Front Pharmacol. 2024 Jan 4;14:1329244. doi: 10.3389/fphar.2023.1329244. eCollection 2023.
7
Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic.
World J Clin Cases. 2022 Sep 16;10(26):9228-9240. doi: 10.12998/wjcc.v10.i26.9228.
8
Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer.
Front Cell Dev Biol. 2022 Jan 12;9:772077. doi: 10.3389/fcell.2021.772077. eCollection 2021.
9
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine.
Genes Dis. 2019 Oct 30;8(2):133-145. doi: 10.1016/j.gendis.2019.10.013. eCollection 2021 Mar.
10
Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.
J Cancer Res Clin Oncol. 2021 May;147(5):1407-1419. doi: 10.1007/s00432-021-03557-y. Epub 2021 Mar 4.

本文引用的文献

1
AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?
J Am Coll Surg. 2013 Aug;217(2):181-90. doi: 10.1016/j.jamcollsurg.2013.04.018. Epub 2013 Jun 12.
2
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152. doi: 10.6004/jnccn.2013.0022.
3
Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.
Lancet Oncol. 2012 Nov;13(11):e470-81. doi: 10.1016/S1470-2045(12)70424-2.
6
MR imaging for preoperative evaluation of primary rectal cancer: practical considerations.
Radiographics. 2012 Mar-Apr;32(2):389-409. doi: 10.1148/rg.322115122.
7
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.
Int J Clin Oncol. 2012 Feb;17(1):1-29. doi: 10.1007/s10147-011-0315-2. Epub 2011 Oct 15.
9
Diagnostic accuracy of computed tomography for colon cancer staging: a systematic review.
Scand J Gastroenterol. 2011 Jul;46(7-8):887-94. doi: 10.3109/00365521.2011.574732. Epub 2011 Apr 20.
10
Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer.
J Clin Oncol. 2011 Jun 1;29(16):2142-3. doi: 10.1200/JCO.2010.34.4473. Epub 2011 Apr 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验